Welcome

Modulation of Genomic and Non-Genomic Signaling Pathways by Xenoestrogens

PI: Tara Sabo-Attwood, Ph.D.
Co-I: P. Lee Ferguson, Ph.D.

This project addresses the potential role of non-genomic estrogen signaling in novel mechanisms of endocrine disruption. Xenoestrogenic compounds are known to act on vertebrate organisms by altering the activity of 17-?-estradiol (E2) at nuclear estrogen receptors (ERs), proteins that form a transcriptional complex that regulates the expression of downstream genes. Although activation or repression of ER activity is a known, genomic-driven mechanism of xenoestrogen action, it does not fully capture the vastly different phenotypic responses of organisms exposed to xenoestrogens. Recently, a membrane receptor, known as the G-protein coupled estrogen receptor (GPER/GPR30) has been implicated in estrogen-responsive, nongenomic signaling pathways, which act through a series of kinase-mediated cascades. GPER therefore represents an alternate and novel estrogen response mechanism that could be a sensitive target of modulation by xenoestrogens. It is likely that opposing, and in some cases convergent crosstalk between the ERs and GPER could occur upon xenoestrogen exposure. Although a number of distinct mechanisms could explain this action, possibilities include; an ‘ER-targeted’ mechanism whereby GPER stimulates kinase activity that acts directly on ERs and/or coregulatory proteins by controlling phosphorylation events that modulate ER-complex activity; ‘ER-non-targeted’ pathways that activate kinases that lead to gene expression independently of ERs. Based on this premise, we hypothesize that GPER acts through kinase-mediated mechanisms to modulate both nuclear-ER-dependent and -independent signaling pathways in a xenoestrogen-specific manner. We intend to test this hypothesis using an integrated functional proteomic and molecular biology approach to address 3 specific aims; (1) Characterize the impact of xenoestrogens on ER and GPER binding, activation and cellular endpoints in lung and breast cells; (2) Assess the influence of xenoestrogens acting through ERs and GPER on kinase activity toward nuclear ER transcriptional complexes and global cell proteins; (3) Assess the role of ERs and GPER in xenoestrogen-initiated phosphorylation of select ER coregulatory proteins in complex recruitment through defined kinase pathways. The expected outcomes will reveal whether ERs and GPER contribute collectively and/or independently to differential gene regulation and cellular processes impacted by xenoestrogens. This contribution is significant, as results illuminate mechanisms by which xenoestrogens act through distinct receptors, highlighting a potentially novel and highly relevant mechanism of endocrine disruption.

 

© University of Florida
Contact ned@cop.ufl.edu for questions about this website

Project Overview

Research Projects

Support Core

Superfund Faculty

Training Core

Translation Core

Community Engagement Core

Upcoming Events

Related Sites

Members Only

Contact Information

Margaret O. James, Ph.D., D.Sc.
Program Director
University of Florida
Department of Medicinal Chemistry
P.O. Box 100485
Gainesville, FL 32610
Phone: (352) 273 7707
Fax: (352) 846-1972
Email mojames@ufl.edu

Stephen M. Roberts, Ph.D.
Co-director
University of Florida
Center for Environmental & Human Health
P.O. Box 110885
Gainesville, FL 32611
Phone: (352) 294 4514
Fax: (352) 392 4707
Email: smroberts@ufl.edu